Unlocking translational proteomics for the
next stage of human health
Unlocking translational proteomics for the
next stage of human health
Range Bio Named Innovation AveNEW company at SLAS 2025
Range Bio was selected as one of 18 of the most innovate startups an application in high-throughput laboratory sciences.
Range Bio Named Innovation AveNEW company at SLAS 2025
Range Bio was selected as one of 18 of the most innovate startups an application in high-throughput laboratory sciences.
Developing Translational Proteomics For The Next Human Health Stage
Range Biotechnologies is a company developing translational proteomics (proteins) for the next stage of human health. Pulse 2.0 interviewed Range Biotechnologies co-founder and CEO Brandon Wilson, Ph.D., to learn more.
Developing Translational Proteomics For The Next Human Health Stage
Range Biotechnologies is a company developing translational proteomics (proteins) for the next stage of human health. Pulse 2.0 interviewed Range Biotechnologies co-founder and CEO Brandon Wilson, Ph.D., to learn more.